Funding from Breast Cancer Now supports research into new drugs for secondary breast cancer in the bone

Researchers are testing new combinations of drugs to treat breast cancer that’s spread to the bone, thanks to funding from Breast Cancer Now.

With $200M investment, Novartis builds out radioligand manufacturing at two sites

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 5, 2024

Nuclera closes $75 million USD financing

Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing

October 16, 2024

Larry Tabak, NIH’s longtime second-in-command, to retire

Larry Tabak, the longtime No. 2 official at the National Institutes of Health, is retiring, according to two sources familiar with his decision. Tabak, a

February 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.